Medical Health & Life Science Research News

Research details developments in the presbyopia therapeutics development and professional review analysis

Research details developments in the presbyopia therapeutics development and professional review analysis

Presbyopia Therapeutics Development and Professional Review Analysis 2017

- Advertisement -

- Restart your WhaTech membership at anytime. -

Summary

Presbyopia Make an Inquiry about this news is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens in people as they age.

Signs and symptoms include headaches, eyestrain, difficulty reading small print and fatigue.

- Advertisement -

- Restart your WhaTech membership at anytime. -
Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis and eye trauma.

Report: www.wiseguyreports.com/sample-requ…-review-h1-2017 Make an Inquiry about this news              

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Presbyopia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Presbyopia (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Presbyopia (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Presbyopia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 5, 1 and 2 respectively.

Presbyopia (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Presbyopia (Ophthalmology).

- The pipeline guide reviews pipeline therapeutics for Presbyopia (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Presbyopia (Ophthalmology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Presbyopia (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Presbyopia (Ophthalmology)

Reasons to access

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Presbyopia (Ophthalmology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Presbyopia (Ophthalmology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points

List of Tables

List of Figures

Introduction

Presbyopia - Overview

Presbyopia - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Presbyopia - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Presbyopia - Companies Involved in Therapeutics Development

Acucela Inc

Allergan Plc

Johnson & Johnson

Novartis AG

Presbyopia - Drug Profiles

(aceclidine + tropicamide) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(oxymetazoline hydrochloride + pilocarpine hydrochloride) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

EV-06 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

lanosterol - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

oxymetazoline hydrochloride - Drug Profile

Product Description

…Continued        

 

ACCESS REPORT at www.wiseguyreports.com/reports/155…-review-h1-2017 Make an Inquiry about this news                                    

 

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...

For more information:

Make an Inquiry about this report HERE!
  • www.wiseguyreports.com/reports/155…ne-review-h1-2017
  • www.wiseguyreports.com/sample-requ…ne-review-h1-2017
  • www.wiseguyreports.com/conferences
  • www.wiseguyreports.com/seminars